Raymond James Financial
PGEN icon

Raymond James Financial’s Precigen PGEN Stock Holding History

Raymond James Financial’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.94M Buy
516,332
+478,950
+1,281% +$2.07M ﹤0.01% 3202
2026
Q1 		$145K Buy
37,382
+200
+0.5% +$821 ﹤0.01% 4954
2025
Q4 		$155K Buy
37,182
+9,013
+32% +$34.9K ﹤0.01% 4848
2025
Q3 		$92.7K Buy
28,169
+10,520
+60% +$29.7K ﹤0.01% 4757
2025
Q2 		$25.1K Buy
17,649
+1,644
+10% +$2.34K ﹤0.01% 5502
2025
Q1 		$23.8K Buy
16,005
+3,200
+25% +$5.04K ﹤0.01% 4705
2024
Q4 		$14.3K Buy
+12,805
New +$10.9K ﹤0.01% 4755

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $3.05B AUM 42.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Raymond James Financial's PGEN Position: Q2 2026 in Review

Raymond James Financial increased its Precigen (PGEN) stake by 1,281% in Q2 2026, buying an estimated $2.07M and bringing the position to 516,332 shares worth $2.94M. The position accounts for ﹤0.01% of the portfolio, ranked #3202.

Raymond James Financial first reported a position in PGEN in Q4 2024 and has held it in 7 quarters since. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • Raymond James Financial held 516,332 shares of Precigen worth $2.94M as of Q2 2026.
  • Raymond James Financial bought 478,950 Precigen shares in Q2 2026, an estimated $2.07M.
  • Precigen made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #3202 holding.
  • Raymond James Financial first reported a position in Precigen in Q4 2024 and has held it in 7 quarters since.
  • 211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.